Let's Combinate - Drugs + Devices

Let's Combinate - Drugs + Devices

Hello Combi-Nation! Our industry fee complicated sometimes. Drugs, devices, clinical trials, submissions, sterilization validation, design control, risk management, market access reimbursement, the list goes on. My name is Subhi Saadeh. I've spent over a decade in medical device, pharma, and combination product development. My goal is mastery, so this podcast is to ask questions I have to people who may have the answers. Whether you're background is Pharma, Device or both, I invite you to listen and together we can simplify by Combinating!

Denne podkasten er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(247)

233 - Most Teams Misunderstand Specifications | ICH Q6

233 - Most Teams Misunderstand Specifications | ICH Q6

ICH Q6 Explained: Specifications, Control Strategy, and What’s Changing in Q6(R1)In this episode of Let’s ComBinate, Subhi continues the ICH Q-series with ICH Q6 and explains why specifications are ce...

8 Apr 6min

232 - MedTech Material Selection: Cost, Compliance, Sustainability, and Biocompatibility Risk

232 - MedTech Material Selection: Cost, Compliance, Sustainability, and Biocompatibility Risk

Subhi Saadeh interviews Lucas Pianegonda, founder of Grad and a plastics expert in medical technology, on how medtech companies actually choose materials—and where it goes wrong. Many teams default to...

1 Apr 34min

231 - Audit Findings Explained: Nonconformity vs Observation (CQA)

231 - Audit Findings Explained: Nonconformity vs Observation (CQA)

This is a lesson out of my ASQ CQA course with Andy Robertson, on how to write and classify audit findings.Access the full CQA course here: https://cqeacademy.teachable.com/p/the-cqa-master-class-cour...

25 Mar 11min

230 - How Pharma Misses Critical Market Signals with Joe Luminiello

230 - How Pharma Misses Critical Market Signals with Joe Luminiello

In this episode of Let’s ComBinate, Subhi Saadeh sits down with Joseph Luminiello, CEO and Co-Founder of RCG Intel, to break down how competitive intelligence is actually used in biopharma and why mos...

23 Mar 30min

229 -Outsourcing Analytical Testing: What Sponsors Get Wrong in Combination Products

229 -Outsourcing Analytical Testing: What Sponsors Get Wrong in Combination Products

In this episode of Let’s Combinate, Subhi Saadeh speaks with Jen Riter about analytical method validation for drug device combination products. The discussion explores how traditional drug analytical ...

11 Mar 31min

228 - ICH Q5 EXPLAINED: Why Regulators Treat Biologics Differently

228 - ICH Q5 EXPLAINED: Why Regulators Treat Biologics Differently

Continuing the ICH Q series with ICH Q5. This episode explains why Q5 exists, how to read it, and what it means for combination products. Q5 addresses quality challenges unique to biologics made in li...

4 Mar 6min

227 - When Should You Open a CAPA? Triggers, Human Error, and Investigation Basics

227 - When Should You Open a CAPA? Triggers, Human Error, and Investigation Basics

Subhi Saadeh sits down with Georg Digel, founder of Elevate CAPA, to break down what should trigger CAPA, and how to investigate the right way using practical tools and better problem statements.Times...

24 Feb 28min

226 - Navigating China NMPA Medical Device Requirements | Standards, GMP Updates, Agents & Classification

226 - Navigating China NMPA Medical Device Requirements | Standards, GMP Updates, Agents & Classification

In this episode, Subhi Saadeh sits down with Elaine (Yi Ling Tan), Creator and Principal Consultant at MedTech Chopsticks, to break down China medical device market access and regulatory compliance un...

18 Feb 29min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
rekommandert
liberal-halvtime
sinnsyn
forskningno
villmarksliv
rss-overskuddsliv
tomprat-med-gunnar-tjomlid
kvinnehelsepodden
rss-paradigmepodden
dekodet-2
rss-zahid-ali-hjelper-deg
rss-rekommandert
rss-inn-til-kjernen-med-sunniva-rose
hva-er-greia-med
psykopoden
rss-lundqvist-podden
tidlose-historier